| 1 |
Uehara Y, Mori C, Noda T, et al. Rescue of embryonic lethality in hepatocyte growth factor/scatter factor knockoutmice [J]．Genesis, 2000, 27(3):99.
|
| 2 |
Liang MQ, Pang LH, Shi L, et al. Expression and significance of matrix metalloproteinase－9 and vascular endothelial growth factor in hypertensive disorders in pregnancy [J]. J Minim Invasive Med, 2010, 5(4):338-339.
|
| 3 |
Chang YL, Li XH, Li P, et al. Expression and significance of vascular endothelial growth factor and matrix metalloproteinase－9 in hypertensive disorders in pregnancy [J]. Matern Child Health Care China, 2010, 25(23):3265-7326.
|
| 4 |
Lin QD. Etiology and prospects of hypertensive disorder complicating pregnancy [J]. Chin J Obstet Gynecol, 2003, 38(8):471-472.
|
| 5 |
Sun ZZ, Wang L, Wang ZR, et al. Research on expression and significance of integrin β3 and TGF－β1 in placenta of patients with hypertensive disorder complicating pregnancy [J]. Chin J Birth Health Hered, 2008, 16(9):25-29.
|
| 6 |
Zhang CL, Wang YX. The role of integrin β3 in human reproduction [J]. J Reprod Med, 2004, 13(2):127-129.
|
| 7 |
Zhang JL, Wang L, Jin YC, et al. Expression of vascular endothelial growth factor and integrin β3 during the angiogenetic process of granulation tissue [J]. Chin J Bases Clin Gen Surg, 2001, 8(6):378-380.
|
| 8 |
Lessey BA. Endometrial integrins and the establishment of uterine receptivity [J]. Hum Reprod，1998，13(Suppl 3):247-258.
|
| 9 |
Lessey BA, Arnold JT. Paracrine signaling in the endometrium integrins and the estalishment of uterine receptivity [J]. J Reprod Immunol, 1998, 39(122):105-116.
|
| 10 |
Sutherland AE, Calarco PG, Damsky CH. Developmental regulationon integrin expression at the time of implantation in the mouse embryo [J]. Development, 1993, 199(4):1175-1186.
|
| 11 |
Massuto DA, Kneese EC, Johnson GA, et al. Transforming growth factor beta (TGF－B) signaling is activated during porcine implantation: Proposed role for latency－associated peptide interactions with integrins at the conceptus－maternal interface [J]. Reproduction, 2010, 139(2):465-478.
|
| 12 |
Li Z, Wang ZB, Gu ML. The role of integrin in embryo implantation, growth and certain diseases in obstetrics and gynecology [J]. Chin J Obstet Gynecol, 1999, 34:254-256.
|
| 13 |
Lin Q, Ma M. Integrins and apoptosis [J]. Int Mol Biol, 1997, 19:112-115.
|
| 14 |
Cai X, Qi GD, Geng LH, et al. Relationship between expression of integrin α1, β1 and apoptosis in placenta of pregnancy induced hypertension syndrome [J]. Chin J Perinat Med, 2005, 8(1):13-16.
|
| 15 |
Li CL, Hu ZH, Cao LY, et al. Study on apoptosis and its related genes in pregnancy induced hypertension [J]. Chin J Obstet Gynecol, 2000, 35:335-337.
|
| 16 |
Wang J. Trophoblast adhesion of the per－implantation mouse blast cyst is regulated by integrin signaling that targets phospholipase [J]. Dev Biol, 2007, 302(1):143-153.
|
| 17 |
Xu P, Wang Y. Effect of matrix proteins on the expression of matrix metalloproteinase－2, －9，anttissue inhibitors of metalloproteinase in human cytotrophoblast cells during the first trimester[J]．Biol Reprod, 2001, 65(1):240-246.
|
| 18 |
Okamoto T, Niu R, Yamada S, et al. Reduced expression of tissue inhibitor of metalloproteinase TIM P22 in gestational tropoblastic diseases[J]. Mol Hum Reprod, 2002, 8(4):392-398.
|
| 19 |
Tang Y, Zhang S. Correlated study of integrin and ovarian cancer [J]. Med Recapitulate, 2008, 14(1):80-81.
|
| 20 |
Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor－beta－1(TGF－β1) in autoimmune disease[J]. J Autoimmun, 2000, 14:23-42.
|
| 21 |
McCaffrey TA. TGF－beta and TGF－beta receptors in atherosclerosis [J]. Cytokine Growth Factor Rev, 2000, 11(122):103.
|
| 22 |
Seay U, Sedding D, Krick S, et al. Transforming growth factor－beta－dependent growth inhibition in primary vascular smooth muscle cells is p38－dependent [J]. J Pharmacol Exp Ther, 2005, 315(3):1005-1012.
|
| 23 |
Xu XY, Chen HP. The expression of transforming growth factor－β1 in pregnancy－induced hypertension and the relationship between the TGF－β1 and serum VCAM－1 [J]．Guangdong Med J, 2004, 25(2):1391-1393.
|
| 24 |
Grisaru GS, Salah Z, Mao ZM, et al. Differential expression of protease activated receptor 1 (Par1) and pY397FAKin benign and malignant human ovarian tissue samples[J]．Int J Cancer, 2005, 113(3):372-378.
|
| 25 |
Mitra SK, Hanson DA, Schlaepfer DD. Focaladhesion kinase: In command and control of cell motility [J]. Nat Rev Mol Cell Bio, 2005, 6(1):56-68.
|
| 26 |
Morla AO, Mogford JE. Control of smooth muscle cell proliferation and phenotype by integrin signaling through focal adhesion kinase [J]. Biochem Biophys Res Commun, 2000, 272(1):298-302.
|
| 27 |
Yin H, Wang LH, Huo Y, et al. Focal adhesion kinase and mitogen activated protein kinase are involved in vascular smooth muscle cells migration and proliferation stimulated by fibronectin [J]. Nation Med J China, 2002, 82(9):622-625.
|
| 28 |
Liu L, Craig AW, Meldrum HD, et al. Apolipoprotein(a) stimulates vascular endothelial cell growth and migration and signals through integrin alpha Vbeta3 [J]. Biochem J, 2009, 418(2):325-336.
|
| 29 |
Ventura JJ, Kennedy NJ, Flave RA, et al. JNK regulates autocrine expression of TGF－beta1[J]. Mol Cell, 2004, 15(2):269-278.
|
| 30 |
Wei CY, Wang MH, Wei YF, et al. Effects of apolipoprotein (a) on vascular smooth muscle cells proliferation and cell signal transduction pathway [J]. Chin J Pathophysiol, 2009, 25(11):2122-2125.
|
| 31 |
Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor－beta－1(TGF－β1)in autoimmune disease [J]. J Autoimmun, 2000, 14:23-42.
|
| 32 |
Zeiler M, Leiser R, Johnson GA, et al. Development of an invitromodel for bovine placentation: A comparison of the in vivo and in vitro expression of integrins and components of extracellular matrix in bovine placental cells[J]．Cells Tissues Organs, 2008, 186(4):229-242.
|
| 33 |
Zhang ZH, Sun ZZ, Dong L, et al. Expression of MMP－9 and Integrin β3 in placenta of hypertensive disorder complicating pregnancy [J]. Chin J Birth Health Hered, 2008, 16(5):12-14.
|